Literature DB >> 22198155

Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.

Siobán B Keel1, Susan Phelps, Kathleen M Sabo, Monique N O'Leary, Catherine B Kirn-Safran, Janis L Abkowitz.   

Abstract

Diamond-Blackfan anemia is a congenital hypoproliferative macrocytic anemia and 5q- syndrome myelodysplastic syndrome is an acquired hypoproliferative macrocytic anemia. Their common erythroid phenotype reflects a shared pathophysiology-haploinsufficiency of one of many ribosomal proteins and somatic deletion of one allele of the ribosomal protein S14 gene, respectively. Although these abnormalities lead to defective ribosome biogenesis, why ribosomal protein hemizygosity results in anemia is not certain. Here, we characterize the hematopoietic phenotype of mice lacking one allele of the ribosomal protein S6 gene. The mice have an erythroid phenotype similar to both Diamond-Blackfan anemia and the 5q- syndrome and lenalidomide therapy improves their anemia. Copyright Â
© 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198155      PMCID: PMC3319152          DOI: 10.1016/j.exphem.2011.12.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  26 in total

1.  Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI).

Authors:  T N Willig; C M Niemeyer; T Leblanc; C Tiemann; A Robert; J Budde; A Lambiliotte; E Kohne; G Souillet; S Eber; J L Stephan; R Girot; P Bordigoni; G Cornu; S Blanche; J M Guillard; N Mohandas; G Tchernia
Journal:  Pediatr Res       Date:  1999-11       Impact factor: 3.756

2.  Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome.

Authors:  Kelly A McGowan; Wendy W Pang; Rashmi Bhardwaj; Marcelina G Perez; John V Pluvinage; Bertil E Glader; Reem Malek; Susan M Mendrysa; Irving L Weissman; Christopher Y Park; Gregory S Barsh
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

3.  Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.

Authors:  Keith Dredge; Rebecca Horsfall; Simon P Robinson; Ling-Hua Zhang; Ling Lu; Yang Tang; Michael A Shirley; George Muller; Peter Schafer; David Stirling; Angus G Dalgleish; J Blake Bartlett
Journal:  Microvasc Res       Date:  2005-01       Impact factor: 3.514

4.  Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Authors:  Alan List; Gordon Dewald; John Bennett; Aristotle Giagounidis; Azra Raza; Eric Feldman; Bayard Powell; Peter Greenberg; Deborah Thomas; Richard Stone; Craig Reeder; Kenton Wride; John Patin; Michele Schmidt; Jerome Zeldis; Robert Knight
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit.

Authors:  J L Abkowitz; K M Sabo; B Nakamoto; C A Blau; F H Martin; K M Zsebo; T Papayannopoulou
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

6.  Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response.

Authors:  Sanda Sulic; Linda Panic; Martina Barkic; Mladen Mercep; Miljana Uzelac; Sinisa Volarevic
Journal:  Genes Dev       Date:  2005-12-15       Impact factor: 11.361

7.  Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation.

Authors:  Hans Matsson; Edward J Davey; Natalia Draptchinskaia; Isao Hamaguchi; Andreas Ooka; Per Levéen; Erik Forsberg; Stefan Karlsson; Niklas Dahl
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia.

Authors:  D G Nathan; B J Clarke; D G Hillman; B P Alter; D E Housman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.

Authors:  B E Glader; K Backer; L K Diamond
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

10.  Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect.

Authors:  Yaw Ohene-Abuakwa; Karen A Orfali; Carine Marius; Sarah E Ball
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

View more
  11 in total

1.  Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.

Authors:  Zhantao Yang; Siobán B Keel; Akiko Shimamura; Li Liu; Aaron T Gerds; Henry Y Li; Brent L Wood; Bart L Scott; Janis L Abkowitz
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

Review 2.  Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

Authors:  Yong Weon Yi; Kyu Sic You; Jeong-Soo Park; Seok-Geun Lee; Yeon-Sun Seong
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 3.  Mouse Models of Erythropoiesis and Associated Diseases.

Authors:  Matthew P Parker; Kenneth R Peterson
Journal:  Methods Mol Biol       Date:  2018

Review 4.  Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells.

Authors:  Bernadette A Chua; Inge Van Der Werf; Catriona Jamieson; Robert A J Signer
Journal:  Cell Stem Cell       Date:  2020-02-06       Impact factor: 24.633

5.  Single-cell analysis of erythropoiesis in Rpl11 haploinsufficient mice reveals insight into the pathogenesis of Diamond-Blackfan anemia.

Authors:  Raymond T Doty; Xiaowei Yan; Changting Meng; Christopher Lausted; Qiang Tian; Janis L Abkowitz
Journal:  Exp Hematol       Date:  2021-02-22       Impact factor: 3.084

Review 6.  Ribosomopathies: how a common root can cause a tree of pathologies.

Authors:  Nadia Danilova; Hanna T Gazda
Journal:  Dis Model Mech       Date:  2015-09       Impact factor: 5.758

7.  In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.

Authors:  Marina E Tourlakis; Siyi Zhang; Heather L Ball; Rikesh Gandhi; Hongrui Liu; Jian Zhong; Julie S Yuan; Cynthia J Guidos; Peter R Durie; Johanna M Rommens
Journal:  PLoS Genet       Date:  2015-06-09       Impact factor: 5.917

8.  The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1.

Authors:  Monique N O'Leary; Katherine H Schreiber; Yong Zhang; Anne-Cécile E Duc; Shuyun Rao; J Scott Hale; Emmeline C Academia; Shreya R Shah; John F Morton; Carly A Holstein; Dan B Martin; Matt Kaeberlein; Warren C Ladiges; Pamela J Fink; Vivian L Mackay; David L Wiest; Brian K Kennedy
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

9.  Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia.

Authors:  Alison M Taylor; Elizabeth R Macari; Iris T Chan; Megan C Blair; Sergei Doulatov; Linda T Vo; David M Raiser; Kavitha Siva; Anindita Basak; Mehdi Pirouz; Arish N Shah; Katherine McGrath; Jessica M Humphries; Emma Stillman; Blanche P Alter; Eliezer Calo; Richard I Gregory; Vijay G Sankaran; Johan Flygare; Benjamin L Ebert; Yi Zhou; George Q Daley; Leonard I Zon
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

10.  Glucocorticoids improve erythroid progenitor maintenance and dampen Trp53 response in a mouse model of Diamond-Blackfan anaemia.

Authors:  Sara E Sjögren; Kavitha Siva; Shamit Soneji; Amee J George; Marcus Winkler; Pekka Jaako; Marcin Wlodarski; Stefan Karlsson; Ross D Hannan; Johan Flygare
Journal:  Br J Haematol       Date:  2015-08-25       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.